We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » LAW ALLOWS GENERIC 'SHARED EXCLUSIVITY,' FDA SAYS
LAW ALLOWS GENERIC 'SHARED EXCLUSIVITY,' FDA SAYS
December 10, 2004
Appearing before a federal appeals court, the FDA defended its policy of granting shared 180-day exclusivity periods to multiple generic firms that are first to challenge different patents on the same drug